Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1971 2
1972 3
1973 10
1974 21
1975 31
1976 35
1977 39
1978 34
1979 46
1980 68
1981 54
1982 61
1983 70
1984 63
1985 66
1986 78
1987 65
1988 81
1989 74
1990 73
1991 75
1992 71
1993 92
1994 73
1995 76
1996 68
1997 92
1998 54
1999 72
2000 53
2001 68
2002 68
2003 76
2004 73
2005 81
2006 58
2007 60
2008 66
2009 54
2010 66
2011 75
2012 81
2013 67
2014 62
2015 71
2016 66
2017 76
2018 70
2019 79
2020 101
2021 84
2022 67
2023 80
2024 74
2025 80
2026 50

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,369 results

Results by year

Filters applied: . Clear all
Page 1
Dantrolene.
Britt BA. Britt BA. Can Anaesth Soc J. 1984 Jan;31(1):61-75. doi: 10.1007/BF03011484. Can Anaesth Soc J. 1984. PMID: 6362802 Review. No abstract available.
Spasticity.
[No authors listed] [No authors listed] Lancet. 1989 Dec 23-30;2(8678-8679):1488-90. Lancet. 1989. PMID: 2574771 Review. No abstract available.
Dantrolene reduces CaMKIIdeltaC-mediated atrial arrhythmias.
Pabel S, Mustroph J, Stehle T, Lebek S, Dybkova N, Keyser A, Rupprecht L, Wagner S, Neef S, Maier LS, Sossalla S. Pabel S, et al. Europace. 2020 Jul 1;22(7):1111-1118. doi: 10.1093/europace/euaa079. Europace. 2020. PMID: 32413138 Free article.
Additional CaMKII inhibition did not further reduce CaSpF or leak compared to dantrolene alone. While the increased SR CaSpF and leak in TG mice were reduced by dantrolene, no effects could be detected in WT. Dantrolene also potently reduced the pathologicall …
Additional CaMKII inhibition did not further reduce CaSpF or leak compared to dantrolene alone. While the increased SR CaSpF and leak …
[Dantrolene. Pharmacological and therapeutic aspects].
Gerbershagen MU, Fiege M, Krause T, Agarwal K, Wappler F. Gerbershagen MU, et al. Anaesthesist. 2003 Mar;52(3):238-45. doi: 10.1007/s00101-003-0461-7. Anaesthesist. 2003. PMID: 12666006 Review. German.
Recent studies identified the ryanodine receptor, the calcium release channel of the sarcoplasmic reticulum, as the direct molecular target of dantrolene. In addition to its use for MH, dantrolene is used in other disorders such as neuroleptic malignant syndrome and …
Recent studies identified the ryanodine receptor, the calcium release channel of the sarcoplasmic reticulum, as the direct molecular target …
Dantrolene.
Hetherington N. Hetherington N. Aust Nurses J. 1992 Mar;21(8):28-9. Aust Nurses J. 1992. PMID: 1605782 No abstract available.
Oral dantrolene.
Allen GC. Allen GC. Anaesthesia. 2004 Nov;59(11):1139; author reply 1139-40. doi: 10.1111/j.1365-2044.2004.03979.x. Anaesthesia. 2004. PMID: 15479327 Free article. No abstract available.
Letter: Dantrolene.
Shaivitz SA. Shaivitz SA. JAMA. 1974 Sep 2;229(10):1282-3. doi: 10.1001/jama.229.10.1282b. JAMA. 1974. PMID: 4408254 No abstract available.
[S1 guidelines on malignant hyperthermia : Update 2018].
Wappler F. Wappler F. Anaesthesist. 2018 Jul;67(7):529-532. doi: 10.1007/s00101-018-0462-1. Anaesthesist. 2018. PMID: 29943228 Review. German.
After the initial treatment with 2.5 mg/kg body weight dantrolene, further therapy using up to 10 mg/body weight dantrolene can be indicated for 24 h. ...For outpatient anesthesia a stockage of dantrolene is not necessary as long as the use of MH trigger subs …
After the initial treatment with 2.5 mg/kg body weight dantrolene, further therapy using up to 10 mg/body weight dantrolene ca …
Dantrolene sodium and hepatic injury.
Chan CH. Chan CH. Neurology. 1990 Sep;40(9):1427-32. doi: 10.1212/wnl.40.9.1427. Neurology. 1990. PMID: 2392230
This is a report on hepatic adverse events associated with dantrolene therapy. All cases reported to the manufacturer are included, from all sources, through 1987. ...Physicians should monitor liver function in patients taking dantrolene....
This is a report on hepatic adverse events associated with dantrolene therapy. All cases reported to the manufacturer are included, f …
3,369 results